Appendix Procedures with MCC DRG | Reimbursement Guide

DRG 397 includes inpatient appendix procedures with a Major Complication or Comorbidity and captures cases with higher clinical complexity. It influences inpatient reimbursement because the Major Complication or Comorbidity designation increases the Diagnosis-Related Group severity and associated Medicare payment weight.

DRG 397 Overview

DRG 397 covers inpatient admissions for patients undergoing appendix procedures when a Major Complication or Comorbidity is present. Typical cases include appendectomy or appendiceal drainage with significant comorbid conditions or complications that increase resource use. This Diagnosis-Related Group matters for Centers for Medicare & Medicaid Services payment because the presence of a Major Complication or Comorbidity increases the relative severity and reimbursement weight. Hospitals and coders must accurately capture operative and secondary diagnosis detail to align claims with appropriate inpatient reimbursement.

Acute surgical intervention trials assessing timing and technique for complicated appendicitis with major complications (e.g., perforation, generalized peritonitis, sepsis): these studies enroll adult and pediatric inpatients presenting with appendiceal rupture, gangrene, or intra‑abdominal abscess requiring urgent operative management, comparing early definitive appendectomy versus initial source-control with percutaneous drainage followed by delayed surgery. The objective is to determine effects on mortality, organ dysfunction, length of intensive care stay, and rates of reoperation; results are directly relevant to surgeons, hospitalists, and payers because they inform resource utilization, ICU needs, and coding/DRG assignment for high‑acuity admissions.
Comparative effectiveness studies of perioperative infection control and antimicrobial strategies in appendix procedures with major complications: these trials compare antibiotic regimens, duration of therapy, and adjunctive measures (for example, intraoperative irrigation protocols or wound management approaches) in patients with complicated appendicitis and associated sepsis or intra‑abdominal contamination. The population includes medically complex inpatients (older adults, immunocompromised, comorbid organ dysfunction) and the research addresses readmission rates for intra‑abdominal infection, length of stay, and downstream costs — information that helps hospitals and payers optimize formularies, stewardship programs, and bundled payment models.
Post-discharge outcomes and rehabilitation studies focusing on functional recovery, complications, and health‑related quality of life after complicated appendiceal procedures: prospective cohort or pragmatic trials follow patients after discharge to measure rates of wound complications, hernia formation, chronic pain, return to baseline activities, and use of post‑acute services (home health, skilled nursing). This research targets high‑risk subgroups (frail elderly, patients with prolonged ICU stays or organ failure) and is important for care managers and payers because it quantifies post‑acute care needs, readmission risk, and long‑term costs associated with the DRG population.

Acute surgical intervention trials assessing timing and technique for complicated appendicitis with major complications (e.g., perforation, generalized peritonitis, sepsis): these studies enroll adult and pediatric inpatients presenting with appendiceal rupture, gangrene, or intra‑abdominal abscess requiring urgent operative management, comparing early definitive appendectomy versus initial source-control with percutaneous drainage followed by delayed surgery. The objective is to determine effects on mortality, organ dysfunction, length of intensive care stay, and rates of reoperation; results are directly relevant to surgeons, hospitalists, and payers because they inform resource utilization, ICU needs, and coding/DRG assignment for high‑acuity admissions.
Comparative effectiveness studies of perioperative infection control and antimicrobial strategies in appendix procedures with major complications: these trials compare antibiotic regimens, duration of therapy, and adjunctive measures (for example, intraoperative irrigation protocols or wound management approaches) in patients with complicated appendicitis and associated sepsis or intra‑abdominal contamination. The population includes medically complex inpatients (older adults, immunocompromised, comorbid organ dysfunction) and the research addresses readmission rates for intra‑abdominal infection, length of stay, and downstream costs — information that helps hospitals and payers optimize formularies, stewardship programs, and bundled payment models.
Post-discharge outcomes and rehabilitation studies focusing on functional recovery, complications, and health‑related quality of life after complicated appendiceal procedures: prospective cohort or pragmatic trials follow patients after discharge to measure rates of wound complications, hernia formation, chronic pain, return to baseline activities, and use of post‑acute services (home health, skilled nursing). This research targets high‑risk subgroups (frail elderly, patients with prolonged ICU stays or organ failure) and is important for care managers and payers because it quantifies post‑acute care needs, readmission risk, and long‑term costs associated with the DRG population.

OpenPayer

Summary & Overview

Appendix Procedures with Major Complication or Comorbidity: Inpatient Reimbursement Overview

DRG 397 Overview

Clinical Trials

Related Codes

Clinical Trials

Related Codes